Evidence map›Paper›PMID 41358445›Full record

ArticleInteractive journal of medical research2025

Impact of the COVID-19 Pandemic on Contraceptive Services at Selected Primary Health Care Facilities in India, Nigeria, and Tanzania: Cross-Sectional Study.

Rita Kabra, Beena Joshi, Ester Elisaria, Tanimola Makanjuola Akande, Komal Preet Allagh, Adesola Olumide, Deepti Tandon, Ranjan Prusty, Mary Ramesh, Donat Shamba and 3 more

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rita KabraDepartment of Sexual and Reproductive Health and Research, including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Avenue Appia 20, Geneva, 1211, Switzerland, 41 796036224.ORCID http://orcid.org/0000-0001-6595-2035
Beena JoshiDepartment of Operational and Implementation Research, ICMR National Institute for Research in Reproductive and Child Health, Mumbai, India.ORCID http://orcid.org/0000-0003-2187-4922
Ester ElisariaDepartment of Health System Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania.ORCID http://orcid.org/0000-0002-7106-2423
Tanimola Makanjuola AkandeDepartment of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria.ORCID http://orcid.org/0000-0002-5220-8669
Komal Preet AllaghDepartment of Sexual and Reproductive Health and Research, including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Avenue Appia 20, Geneva, 1211, Switzerland, 41 796036224.ORCID http://orcid.org/0000-0002-6272-2135
Adesola OlumideInstitute of Child Health, University of Ibadan, Ibadan, Nigeria.ORCID http://orcid.org/0000-0003-4372-9822
Deepti TandonDepartment of Clinical Research, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, India.ORCID http://orcid.org/0000-0001-7889-7346
Ranjan PrustyDepartment of Biostatistics, ICMR- National Institute for Research in Reproductive and Child Health, Mumbai, India.ORCID http://orcid.org/0000-0001-7972-6725
Mary RameshDepartment of Health System Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania.ORCID http://orcid.org/0000-0002-4942-3923
Donat ShambaDepartment of Health System Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania.ORCID http://orcid.org/0000-0001-7431-7199
Bhavya MkDepartment of Operational and Implementation Research, ICMR National Institute for Research in Reproductive and Child Health, Mumbai, India.ORCID http://orcid.org/0009-0002-3395-433X
Shabana KhanDepartment of Operational and Implementation Research, ICMR National Institute for Research in Reproductive and Child Health, Mumbai, India.ORCID http://orcid.org/0000-0002-8129-6688
James KiarieDepartment of Sexual and Reproductive Health and Research, including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Avenue Appia 20, Geneva, 1211, Switzerland, 41 796036224.ORCID http://orcid.org/0000-0003-4180-7858

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: The COVID-19 pandemic disrupted sexual and reproductive health services, including family planning (FP) and contraceptive services. The World Health Organization conducted a multicountry study in India, Nigeria, and Tanzania to determine the impact of the pandemic on the health system's readiness to provide contraception services and trends in contraceptive uptake. Objective: This study aimed to determine the status, availability, and health facility readiness to provide contraceptive services and to compare trends in contraceptive uptake before and during the pandemic. Methods: This cross-sectional study was conducted by the Indian Council of Medical Research-National Institute of Research in Reproductive and Child Health (India), the University of Ilorin Teaching Hospital (Nigeria), and the Ifakara Health Institute (Tanzania). A total of 50 primary health facilities (11 in India, 6 in Nigeria, and 33 in Tanzania) were evaluated using a standardized facility assessment questionnaire, completed by the most knowledgeable senior health care provider or administrator at the facility. Monthly data on service utilization and contraceptive availability were collected to capture trends before and during the COVID-19 pandemic. Data were collected from May to August 2022. The study received ethical and scientific approval from the World Health Organization Ethics Review Committee and Research Project Review Panel and national regulatory bodies. Key outcomes included availability of FP guidelines and tools, service disruptions including contraceptive and abortion services, stock-outs, reasons for service disruptions, and mitigation measures to sustain service deliveries. Descriptive analysis was used to summarize the key trends and patterns. Results: Health facilities in all three countries reported shortages of various contraceptives. Contraceptive services were partially disrupted in 91% facilities in India, 83% facilities in Nigeria, and 43% facilities in Tanzania. Abortion services were partially disrupted in all surveyed facilities offering these services in India and Nigeria and in 26.7% of facilities in Tanzania. Client visits declined in health facilities in 2020 compared to 2019 in India (30%) and Nigeria (11%), with a gradual recovery thereafter. In contrast, Tanzania experienced a 1% decline in client visits in 2020. Readiness measures such as telemedicine, task shifting, community outreach, triaging, and patient redirection were implemented to minimize service disruptions. Conclusions: This study provides crucial insights into the challenges posed by the COVID-19 pandemic on contraceptive services and the measures taken to alleviate them. The findings can help countries to better prepare to prevent the disruption of FP and contraceptive services in future pandemics or emergencies.

Indexed as

contraceptivecontraceptivesCOVID-19COVID-19 pandemicfacility assessmentfamily planningIndiamixed methodNigeriaprimary health careTanzaniaWorld Health Organization

Identifiers

PMID41358445
PMCPMC12683499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.